These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24210767)

  • 21. How to demonstrate similarity by using noninferiority and equivalence statistical testing in radiology research.
    Ahn S; Park SH; Lee KH
    Radiology; 2013 May; 267(2):328-38. PubMed ID: 23610094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of bias assessment of randomised controlled trials in high-impact ophthalmology journals and general medical journals: a systematic review.
    Joksimovic L; Koucheki R; Popovic M; Ahmed Y; Schlenker MB; Ahmed IIK
    Br J Ophthalmol; 2017 Oct; 101(10):1309-1314. PubMed ID: 28659390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies.
    Fung AE; Palanki R; Bakri SJ; Depperschmidt E; Gibson A
    Ophthalmology; 2009 Feb; 116(2):286-96. PubMed ID: 19091408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothesis testing in noninferiority and equivalence MRMC ROC studies.
    Chen W; Petrick NA; Sahiner B
    Acad Radiol; 2012 Sep; 19(9):1158-65. PubMed ID: 22717591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed noninferiority margin and statistical tests in active controlled trials.
    Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
    J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chinese authors do need CONSORT: reporting quality assessment for five leading Chinese medical journals.
    Xu L; Li J; Zhang M; Ai C; Wang L
    Contemp Clin Trials; 2008 Sep; 29(5):727-31. PubMed ID: 18579449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equivalence and noninferiority testing in regression models and repeated-measures designs.
    Mascha EJ; Sessler DI
    Anesth Analg; 2011 Mar; 112(3):678-87. PubMed ID: 21304155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Randomized controlled and controlled clinical trials in German-language ophthalmological journals].
    Schmucker C; Blümle A; Antes G; Lagrèze W
    Ophthalmologe; 2008 Mar; 105(3):255-61. PubMed ID: 17899115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reporting of noninferiority and equivalence randomized trials for major prostaglandins: a systematic survey of the ophthalmology literature.
    Eyawo O; Lee CW; Rachlis B; Mills EJ
    Trials; 2008 Dec; 9():69. PubMed ID: 19055743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the noninferiority margin and analysing noninferiority: An overview.
    Althunian TA; de Boer A; Groenwold RHH; Klungel OH
    Br J Clin Pharmacol; 2017 Aug; 83(8):1636-1642. PubMed ID: 28252213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.
    Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP
    J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic qualitative review of randomised trials conducted in nonsmall cell lung cancer with a noninferiority or equivalence design.
    Paesmans M; Grigoriu B; Ocak S; Roelandts M; Lafitte JJ; Holbrechts S; Berghmans T; Meert AP; Moretti L; Danyi S; Pasleau F; Ameye L; Van Meerhaeghe A; Sculier JP
    Eur Respir J; 2015 Feb; 45(2):511-24. PubMed ID: 25537559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled trials: what are they and who needs them?
    Pihlstrom BL; Curran AE; Voelker HT; Kingman A
    Periodontol 2000; 2012 Jun; 59(1):14-31. PubMed ID: 22507057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Most noninferiority trials were not designed to preserve active comparator treatment effects.
    Tsui M; Rehal S; Jairath V; Kahan BC
    J Clin Epidemiol; 2019 Jun; 110():82-89. PubMed ID: 30858020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence reporting in randomized controlled trials.
    Zhang Z; Peluso MJ; Gross CP; Viscoli CM; Kernan WN
    Clin Trials; 2014 Apr; 11(2):195-204. PubMed ID: 24357665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypotheses and type I error in active-control noninferiority trials.
    Chen G; Wang YC; Chi GY
    J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons from and cautions about noninferiority and equivalence randomized trials.
    Gøtzsche PC
    JAMA; 2006 Mar; 295(10):1172-4. PubMed ID: 16522840
    [No Abstract]   [Full Text] [Related]  

  • 40. Another point of view: superiority, noninferiority, and the role of active comparators.
    Kraemer HC
    J Clin Psychiatry; 2011 Oct; 72(10):1350-2. PubMed ID: 22075101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.